CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. Tebas P, Jadlowsky JK, Shaw PA, Tian L, et al. J Clin Invest 2024;134:e181576.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tebas P, Jadlowsky JK, Shaw PA, Tian L, et al. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. J Clin Invest 2024;134:e181576.
PMID: 38690741